Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant bovine basic fibroblast growth factor
- Development stage
- Phase 2
- Lead developer
- Essex Bio-Technology
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
Recombinant bovine basic fibroblast growth factor (rb-bFGF) is a biologically active protein produced using recombinant DNA technology. It mimics the natural basic fibroblast growth factor derived from bovine sources and acts as a potent mitogen that stimulates cellular proliferation and differentiation. Its primary mechanism of action involves promoting tissue repair and regeneration by enhancing granulation tissue formation and epidermal regeneration. Clinically, rb-bFGF is used to accelerate wound healing in burns, donor sites, chronic dermal ulcers, oral mucositis induced by chemotherapy or radiotherapy, and skin ulceration associated with rosacea lesions[1][4][8]. The drug has demonstrated efficacy in reducing healing time for various wounds and improving overall wound quality[4]. Recombinant production allows for large-scale manufacturing compared to traditional extraction methods[6].
- Brand names
- Beifuxin
- Other names
- FGFbasic fibroblast growth factor (bovine)FGF-2 (bovine)Fibroblast Growth Factor-Basic from bovine pituitary
02
Targets
FGFR3 (Fibroblast growth factor receptor 3)
Beyond the preview
Go deeper on recombinant bovine basic fibroblast growth factor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant bovine basic fibroblast growth factor.